| Stage | SYK | % of rev | HAE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.5B | 100.00% | $358M | 100.00% | SYK ×18.22 |
| Gross profit | $4.2B | 65.15% | $221M | 61.75% | SYK +3.4pp |
| Operating income | $1.0B | 15.86% | $75M | 21.00% | HAE +5.1pp |
| Pre-tax income | $997M | 15.29% | $63M | 17.57% | HAE +2.3pp |
| Net income | $753M | 11.55% | $46M | 12.94% | HAE +1.4pp |
| Stage | SYK | HAE | Gap · A − B |
|---|---|---|---|
| Revenue | $6.5B100.00% | $358M100.00% | SYK ×18.22 |
| Gross profit | 65.15%$4.2B | 61.75%$221M | SYK +3.4pp |
| Operating income | 15.86%$1.0B | 21.00%$75M | HAE +5.1pp |
| Pre-tax income | 15.29%$997M | 17.57%$63M | HAE +2.3pp |
| Net income |
| 11.55%$753M |
| 12.94%$46M |
| HAE +1.4pp |